Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human prion diseases.

Man-Sun Sy1, Pierluigi Gambetti, Boon-Seng Wong

  • 1Division of Neuropathology, Institute of Pathology, and Cancer Research Center, Room 933 Biomedical Research Building, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44120-1712, USA. mxs92@po.cwru.edu

The Medical Clinics of North America
|August 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genes.

Brain : a journal of neurology·2025
Same author

Collagen prolyl 4-hydroxylase subunit α member-induced head and neck squamous cell carcinoma aggressiveness is antagonized by LLGL2 via reduced expression of occludin.

Acta biochimica et biophysica Sinica·2024
Same author

Genome wide association study of clinical duration and age at onset of sporadic CJD.

PloS one·2024
Same author

Sensitive detection of pathological seeds of α-synuclein, tau and prion protein on solid surfaces.

PLoS pathogens·2024
Same author

Efficient transmission of human prion diseases to a glycan-free prion protein-expressing host.

Brain : a journal of neurology·2023
Same author

Detection of prions in the urine of patients affected by sporadic Creutzfeldt-Jakob disease.

Annals of clinical and translational neurology·2023
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Transmissible spongiform encephalopathies (TSEs) are rare, fatal neurodegenerative diseases affecting humans and animals. This review covers TSE diseases, their inherited nature, current treatments, and future research directions.

Area of Science:

  • Neuroscience
  • Pathology
  • Genetics

Background:

  • Transmissible spongiform encephalopathies (TSEs) are a class of rare, fatal neurodegenerative disorders.
  • These diseases affect both humans and animals, characterized by sub-acute progression.
  • Examples include Creutzfeldt-Jakob disease, Gerstmann-Sträussler-Scheinker disease, fatal familial insomnia, and Kuru.

Purpose of the Study:

  • To describe the spectrum of transmissible spongiform encephalopathies.
  • To review current therapeutic approaches for TSEs.
  • To identify promising avenues for future research in the field.

Main Methods:

  • Literature review of existing studies on TSEs.
  • Analysis of disease characteristics, including familial clustering and inheritance patterns.

Related Experiment Videos

  • Synthesis of information on current treatment modalities and research trends.

    • Main Results:

    • TSEs exhibit diverse clinical presentations and pathologies.
    • Some TSEs demonstrate a clear inherited or familial pattern of occurrence.
    • Current treatment options for TSEs are limited, with ongoing research exploring novel therapeutic strategies.

    Conclusions:

    • Understanding the genetic and sporadic forms of TSEs is crucial for developing effective interventions.
    • Further research is needed to elucidate disease mechanisms and identify viable treatments for these devastating neurodegenerative conditions.